Sattar T, Jilani K, Parveen K, Mushataq Z, Nawaz H, Khan MAB. Induction of Erythrocyte Membrane Blebbing by Methotrexate-Induced Oxidative Stress.
Dose Response 2022;
20:15593258221093853. [PMID:
35449724 PMCID:
PMC9016546 DOI:
10.1177/15593258221093853]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Methotrexate (MTX) is a common chemotherapeutical agent and folate antagonist with
reported apoptotic activity in nucleated cells. The presented research work was planned to
investigate the eryptotic effects of methotrexate after the exposure of erythrocytes to
therapeutical doses (10–15 μM) of methotrexate. Eryptosis and the role of calcium in the
stimulation of membrane blebbing were evaluated through the determination of mean cell
volume. Oxidative stress induced by methotrexate (10–15 μM) was determined by
antioxidative enzyme activities. Cytotoxic activity against human erythrocytes was
examined through hemolysis assay. Exposure of erythrocytes to methotrexate results in
significant reduction of superoxide dismutase, catalase, and superoxide dismutase
activities at 10 and 15 μM in comparison to the untreated cells. Erythrocytes mean cell
volume (MCV) was increased after 48 hours exposure of erythrocytes to methotrexate
(10 μM). Significantly increased hemolysis percentage was observed at 10 μM after 48 hours
incubation of erythrocytes with methotrexate. The results of the study suggested that the
therapeutical doses (10–15 μM) of methotrexate may lead to increase in eryptotic and
hemolytic activity of erythrocytes through free radical generation and subsequent calcium
entry.
Collapse